Top

Indian Journal of Hematology and Blood Transfusion

Published in:

01-09-2014 | Case Report

An Interesting Case of CMV Retinitis in a Case of ALL on Maintenance Therapy

Authors: Pawan Kumar Singh, Aniruddha Purushottam Dayama, Rakhi Maiwall, Vineet Sehgal, Pradeep Venkatesh, Pravas Chandra Mishra, Tulika Seth, Manoranjan Mahapatra

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2014

Abstract

Forty-five years old male, a known case of T cell acute lymphoblastic leukemia (ALL) on maintenance therapy presented with bilateral painless progressive diminution of vision. Evaluation revealed cytomegalovirus (CMV) retinitis with low CD4 counts. CMV retinitis is usually seen in HIV disease or in post allogenic stem cell transplant recipients. CMV retinitis occurring in ALL maintenance phase is very rare. The disease is aggressive and shows incomplete response to medical therapy.

Ljungman Per (2002) Definitions of CMV infections and disease in transplant recipients. Clin Infect Dis 34:1094–1097PubMedCrossRef

Wakai K, Sano H, Shimada A, Shiozawa Y, Hayashi Y, Park MJ, Sotomatsu M, Yanagisawa R, Koike K, Kozawa K, Ryo A, Tsukagoshi H, Kimura H (2013) Cytomegalovirus retinitis during maintenance therapy for T-cell acute lymphoblastic leukemia. J Pediatr Hematol Oncol 35(2):162–163PubMedCrossRef

Taha Ruba et al (2010) Two ocular infections during conventional chemotherapy in a patient with acute lymphoblastic leukemia: a case report. Case Rep Oncol 3:234–239. doi:10.1159/000318230 PubMedCrossRefPubMedCentral

Alemayehu W, Shamebo M, Bedri A, Mengistu Z (1996) Ocular manifestations of leukaemia in Ethiopians. Ethiop Med J 34:217–224 ISSN 0014-1755PubMed

Libby E, Movva S, Quintana D, Abdul-Jaleel M, Das A (2010) Cytomegalovirus retinitis during chemotherapy with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone. J Clin Oncol 28(32):e661–e662PubMedCrossRef

Nichols WG, Boeckh MJ (2000) Recent advances in the therapy and prevention of CMV infections. J Clin Virol 16:25–40PubMedCrossRef

Shibata K, Shimamoto Y, Nishimura T, Okinami S, Yamada H, Miyahara M (1997) Ocular manifestation in adult T cell leukaemia/lymphoma. Ann Hematol 74:163–168 ISSN 0939-5555PubMedCrossRef

Cogan et al DG (1977) Immunosuppression and eye disease. Am J Ophthalmol 83:777–788 ISSN 0002-9394CrossRef

Meredith TA, Aaberg TM, Reeser FH (1979) Rhegmatogenous retinal detachment complicating CMV retinitis. Am J Ophthalmol 87:793–796 ISSN 0002-9394PubMedCrossRef

10.

Kobayashi R, Takanashi K, Suzuki D, Nasu T, Uetake K, Matsumoto Y (2012) Retinitis from cytomegalovirus during maintenance treatment for acute lymphoblastic leukemia. Pediatr Int 54(2):288–290PubMedCrossRef

11.

Moritake H, Kamimura S, Kojima H, Shimonodan H, Harada M, Sugimoto T, Nao-I N, Nunoi H (2013) Cytomegalovirus retinitis as an adverse immunological effect of pulses of vincristine and dexamethasone in maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 60(2):329–331PubMedCrossRef

12.

Singh R, Trehan A, Jain R, Bhalekar S (2012) Cytomegalovirus retinitis in an ALL child on exclusive chemotherapy treated successfully with intravitreal ganciclovir alone. J Pediatr Hematol Oncol 26(2):237–240. doi:10.1038/eye.2011.327

13.

Urakami Tomoko, Nishiuchi Ritsuo, Oda Megumi, Takemoto Chikayo, Tomiyama Yoshie, Manki Akira, Seino Yoshiki (2002) Successful treatment of cytomegalovirus retinitis in a child with acute lymphoblastic leukemia during maintenance chemotherapy. Jpn J Pediatr Hematol. 16(5):312–316

Title: An Interesting Case of CMV Retinitis in a Case of ALL on Maintenance Therapy
Authors: Pawan Kumar Singh
Aniruddha Purushottam Dayama
Rakhi Maiwall
Vineet Sehgal
Pradeep Venkatesh
Pravas Chandra Mishra
Tulika Seth
Manoranjan Mahapatra
Publication date: 01-09-2014
Publisher: Springer India
Published in: Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-013-0305-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2014

Autoimmune haemolytic anaemia emerging during Campath treatment in a patient with CD5 negative chronic lymphocytic leukaemia

Pancytopenia and Isolated Bone Marrow Recurrence in a Case of Previously Resected Gastric Carcinoma: A Rare Finding

Histiocytic Sarcoma with Acute Lymphoblastic Leukemia a Rare Association: Case Report and Literature Review

Receptor Conversion in Carcinoma Breast Metastatic to the Bone Marrow

Hypercalcemia in Tumor Lysis Syndrome

Pure Red Cell Aplasia in a Three-Months-Old Infant Possibly Secondary to Cytomegalo Virus Infection

Keynote webinar | Spotlight on antibody–drug conjugates in cancer